Quick Answer
Praxis Precision Medicines, Inc. reported Earnings Per Share Diluted of $13.48 (loss) per share for the year ending 2025.
- Praxis Precision Medicines, Inc. showed a decrease of -32.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Praxis Precision Medicines, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Praxis Precision Medicines, Inc.'s Earnings Per Share Diluted has declined by 71.5%.
- Historical annual values: Fiscal year 2025: $13.48 (loss) per share | Fiscal year 2024: $10.21 (loss) per share | Fiscal year 2023: $18.69 (loss) per share | Fiscal year 2022: $69.65 (loss) per share | Fiscal year 2021: $3.94 (loss) per share | Fiscal year 2020: $7.86 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: